PRLD logo

PRLD EBITDA

Annual EBITDA

-$139.71 M
-$8.61 M-6.56%

December 31, 2024


Summary


Performance

PRLD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRLDprofitabilitymetrics:

Quarterly EBITDA

-$33.83 M
+$140.00 K+0.41%

December 1, 2024


Summary


Performance

PRLD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRLDprofitabilitymetrics:

TTM EBITDA

-$138.43 M
+$3.22 M+2.27%

December 1, 2024


Summary


Performance

PRLD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRLDprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

PRLD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.6%+0.4%+2.3%
3 y3 years-23.8%-2.5%-13.3%
5 y5 years-403.9%-2.5%-13.3%

PRLD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-23.8%at low-17.3%+8.7%-22.7%+2.3%
5 y5-year-403.9%at low-252.2%+8.7%-726.4%+2.3%
alltimeall time-842.4%at low-398.6%+8.7%-1940.3%+2.3%

Prelude Therapeutics Incorporated EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$139.71 M(+6.6%)
-
-
Dec 2024
-
-$33.83 M(-0.4%)
-$138.43 M(-2.3%)
Sep 2024
-
-$33.97 M(-7.5%)
-$141.65 M(+0.6%)
Jun 2024
-
-$36.71 M(+8.2%)
-$140.78 M(+3.4%)
Mar 2024
-
-$33.92 M(-8.5%)
-$136.19 M(+3.9%)
Dec 2023
-$131.11 M(+7.3%)
-$37.05 M(+11.9%)
-$131.11 M(+3.2%)
Sep 2023
-
-$33.11 M(+3.1%)
-$127.08 M(+2.4%)
Jun 2023
-
-$32.12 M(+11.4%)
-$124.05 M(+2.5%)
Mar 2023
-
-$28.84 M(-12.7%)
-$121.07 M(-0.9%)
Dec 2022
-$122.22 M
-$33.02 M(+9.8%)
-$122.22 M(+0.2%)
Sep 2022
-
-$30.07 M(+3.2%)
-$121.91 M(-0.4%)
Jun 2022
-
-$29.14 M(-2.8%)
-$122.41 M(+1.2%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$29.98 M(-8.4%)
-$120.99 M(+7.2%)
Dec 2021
-$112.82 M(+93.8%)
-$32.72 M(+7.0%)
-$112.82 M(+13.5%)
Sep 2021
-
-$30.57 M(+10.3%)
-$99.41 M(+14.5%)
Jun 2021
-
-$27.72 M(+27.1%)
-$86.84 M(+23.3%)
Mar 2021
-
-$21.81 M(+12.9%)
-$70.42 M(+21.0%)
Dec 2020
-$58.22 M(+110.0%)
-$19.31 M(+7.3%)
-$58.22 M(+19.1%)
Sep 2020
-
-$18.00 M(+59.3%)
-$48.88 M(+29.8%)
Jun 2020
-
-$11.30 M(+17.7%)
-$37.66 M(+42.9%)
Mar 2020
-
-$9.61 M(-3.6%)
-$26.36 M(+57.3%)
Dec 2019
-$27.73 M(+87.0%)
-$9.97 M(+46.9%)
-$16.75 M(+146.9%)
Sep 2019
-
-$6.79 M
-$6.79 M
Dec 2018
-$14.83 M
-
-

FAQ

  • What is Prelude Therapeutics Incorporated annual EBITDA?
  • What is the all time high annual EBITDA for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated annual EBITDA year-on-year change?
  • What is Prelude Therapeutics Incorporated quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated quarterly EBITDA year-on-year change?
  • What is Prelude Therapeutics Incorporated TTM EBITDA?
  • What is the all time high TTM EBITDA for Prelude Therapeutics Incorporated?
  • What is Prelude Therapeutics Incorporated TTM EBITDA year-on-year change?

What is Prelude Therapeutics Incorporated annual EBITDA?

The current annual EBITDA of PRLD is -$139.71 M

What is the all time high annual EBITDA for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high annual EBITDA is -$14.83 M

What is Prelude Therapeutics Incorporated annual EBITDA year-on-year change?

Over the past year, PRLD annual EBITDA has changed by -$8.61 M (-6.56%)

What is Prelude Therapeutics Incorporated quarterly EBITDA?

The current quarterly EBITDA of PRLD is -$33.83 M

What is the all time high quarterly EBITDA for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high quarterly EBITDA is -$6.79 M

What is Prelude Therapeutics Incorporated quarterly EBITDA year-on-year change?

Over the past year, PRLD quarterly EBITDA has changed by +$140.00 K (+0.41%)

What is Prelude Therapeutics Incorporated TTM EBITDA?

The current TTM EBITDA of PRLD is -$138.43 M

What is the all time high TTM EBITDA for Prelude Therapeutics Incorporated?

Prelude Therapeutics Incorporated all-time high TTM EBITDA is -$6.79 M

What is Prelude Therapeutics Incorporated TTM EBITDA year-on-year change?

Over the past year, PRLD TTM EBITDA has changed by +$3.22 M (+2.27%)